Skip to main content

Advertisement

SpringerLink
Log in

Cutaneous Manifestations of Human Immunodeficiency Virus: a Clinical Update

  • Skin, Soft Tissue, Bone and Joint Infectious Diseases (N Safdar, Section Editor)
  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

Abstract

Dermatologic diseases are common in the HIV-infected population. Many of the cutaneous diseases are not unique to this group, but the presentation can be more severe. Although the introduction of antiretroviral therapy has been followed by a decline in many of the skin diseases associated with HIV, drug reactions and other non-infectious skin conditions have increased. This article reviews the current spectrum of HIV-associated skin conditions, focusing on common complaints, infections, drug-associated toxicity and malignancies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. UNAIDS (2012) ‘Global Report: UNAIDS Report on the Global AIDS Epidemic 2012’. http://www.avert.org/worldwide-hiv-aids-statistics.htm

  2. CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 U.S. dependent areas—2011. HIV Surveillance Supplemental Report 2013;18(No. 5).

  3. CDC. Estimated HIV incidence in the United States, 2007–2010. HIV Surveillance Supplemental Report 2012;17(No. 4).

  4. Mankahla A, Mosam A. Common skin conditions in children with HIV/AIDS. Am J Clin Dermatol. 2012;13(3):153–66.

    Article  PubMed  Google Scholar 

  5. Cedeno-Laurent F, Gómez-Flores M, Mendez N, Ancer-Rodríguez J, Bryant JL, Gaspari AA, et al. New insights into HIV-1-primary skin disorders. J Int AIDS Soc. 2011;14:5.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Smith KJ, Skelton HG, Yeager J, Ledsky R, McCarthy W, Baxter D, et al. Cutaneous findings in HIV-1-positive patients: a 42-month prospective study. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR). J Am Acad Dermatol. 1994;31(5 Pt 1):746–54.

    Article  CAS  PubMed  Google Scholar 

  7. Rodgers S, Leslie KS. Skin infections in HIV-infected individuals in the era of HAART. Curr Opin Infect Dis. 2011;24(2):124–9.

    Article  PubMed  Google Scholar 

  8. Bolognia J, Jorizzo J, Schaffer J. Dermatology. 3rd ed. Elsevier; 2012

  9. Kaushik SB, Cerci FB, Miracle J, Pokharel A, Chen SC, Chan YH, et al. Chronic pruritus in HIV-positive patients in the southeastern United States: its prevalence and effect on quality of life. J Am Acad Dermatol. 2014;70(4):659–64. This cross sectional study evaluates the most common skin complaints in patients in the US and their effect on the quality of life.

    Article  PubMed  Google Scholar 

  10. Rane SR, Agrawal PB, Kadgi NV, Jadhav MV, Puranik SC. Histopathological study of cutaneous manifestations in HIV and AIDS J Eur Acad Dermatol Venereol. 2013 Feb; 27(2).

  11. Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med. 2005;352(14):1436–44.

    Article  CAS  PubMed  Google Scholar 

  12. Von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study group. N Engl J Med. 2001;344(1):11–6.

    Article  Google Scholar 

  13. Buehlmann M, Frei R, Fenner L, Dangel M, Fluckiger U, Widmer AF. Highly effective regimen for decolonization of methicillin-resistant Staphylococcus aureus carriers. Infect Control Hosp Epidemiol. 2008;29(6):510–6.

    Article  CAS  PubMed  Google Scholar 

  14. Popovich KJ, Weinstein RA, Aroutcheva A, Rice T, Hota B. Community-associated methicillin-resistant Staphylococcus aureus and HIV: intersecting epidemics. Clin Infect Dis. 2010;50(7):979–87.

    Article  PubMed  Google Scholar 

  15. Popovich KJ, Hota B, Aroutcheva A, Kurien L, Patel J, Lyles-Banks R, et al. Community-associated methicillin-resistant Staphylococcus aureus colonization burden in HIV-infected patients. Clin Infect Dis. 2013;56(8):1067–74. This study shows increased MRSA colonization burden in HIV patients and highlights associated risk factors.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Zervou FN, Zacharioudakis IM, Ziakas PD, Rich JD, Mylonakis E. Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus colonization in HIV infection: a meta-analysis. Clin Infect Dis. 2014;59(9):1302–11.

    Article  PubMed  Google Scholar 

  17. Vyas KJ, Shadyab AH, Lin CD, Crum-Cianflone NF. Trends and factors associated with initial and recurrent methicillin-resistant Staphylococcus aureus (MRSA) skin and soft-tissue infections among HIV-infected persons: an 18-year study. J Int Assoc Provid AIDS Care. 2014;13(3):206–13.

    Article  PubMed  Google Scholar 

  18. Kazem S, van der Meijden E, Feltkamp MC. The trichodysplasia spinulosa-associated polyomavirus: virological background and clinical implications. APMIS. 2013;121(8):770–82.

    Article  CAS  PubMed  Google Scholar 

  19. Ehlers B, Wieland U. The novel human polyomaviruses HPyV6, 7, 9 and beyond. APMIS. 2013;121(8):783–95.

    Article  CAS  PubMed  Google Scholar 

  20. Dalianis T, Hirsch HH. Human polyomaviruses in disease and cancer. Virology. 2013;437(2):63–72.

    Article  CAS  PubMed  Google Scholar 

  21. Wieland U, Silling S, Hellmich M, Potthoff A, Pfister H, Kreuter A. Human polyomaviruses 6, 7, 9, 10 and Trichodysplasia spinulosa-associated polyomavirus in HIV-infected men. J Gen Virol. 2014;95(Pt 4):928–32.

    Article  CAS  PubMed  Google Scholar 

  22. Rogers HD, Macgregor JL, Nord KM, Tyring S, Rady P, Engler DE, et al. Acquired epidermodysplasia verruciformis. J Am Acad Dermatol. 2009;60(2):315–20.

    Article  PubMed  Google Scholar 

  23. Vicente A, Pau-Charles I, González-Enseñat MA, Muñoz-Almagro C, Cañadas MP, Noguera-Julian A, et al. High-risk alpha-human papillomavirus types: detection in HIV-infected children with acquired epidermodysplasia verruciformis. J Am Acad Dermatol. 2013;68(2):343–5.

    Article  PubMed  Google Scholar 

  24. Jacobelli S, Laude H, Carlotti A, Rozenberg F, Deleuze J, Morini JP, et al. Epidermodysplasia verruciformis in human immunodeficiency virus-infected patients: a marker of human papillomavirus-related disorders not affected by antiretroviral therapy. Arch Dermatol. 2011;147(5):590–6.

    Article  PubMed  Google Scholar 

  25. Valeyrie-Allanore L, Sassolas B, Roujeau JC. Drug-induced skin, nail and hair disorders. Drug Saf. 2007;30(11):1011–30.

    Article  CAS  PubMed  Google Scholar 

  26. Rzany B, Mockenhaupt M, Stocker U, Hamouda O, Schöpf E. Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with the acquired immunodeficiency syndrome in Germany. Arch Dermatol. 1993;129(8):1059.

    Article  CAS  PubMed  Google Scholar 

  27. Dziuban EJ, Hughey AB, Stewart DA, Blank DA, Kochelani D, Draper HR, et al. Stevens-Johnson syndrome and HIV in children in Swaziland. Pediatr Infect Dis J. 2013;32(12):1354–8.

    Article  PubMed  Google Scholar 

  28. Saka B, Barro-Traoré F, Atadokpédé FA, Kobangue L, Niamba PA, Adégbidi H, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa: a multicentric study in four countries. Int J Dermatol. 2013;52(5):5.

    Article  Google Scholar 

  29. Pereira FA, Mudgil AV, Rosmarin DM. Toxic epidermal necrolysis. J Am Acad Dermatol. 2007.

  30. Azukizawa H, Sano S, Kosaka H, Sumikawa Y, Itami S. Prevention of toxic epidermal necrolysis by regulatory T cells. Eur J Immunol. 2005;35(6):1722–30.

    Article  CAS  PubMed  Google Scholar 

  31. Smith KJ, Skelton HG, Yeager J, Ledsky R, Ng TH, Wagner KF. Increased drug reactions in HIV-1-positive patients: a possible explanation based on patterns of immune dysregulation seen in HIV-1 disease. The Military Medical Consortium for the Advancement of Retroviral Research (MMCARR). Clin Exp Dermatol. 1997;22(3):118–23.

    Article  CAS  PubMed  Google Scholar 

  32. Yang C, Mosam A, Mankahla A, Dlova N, Saavedra A. HIV infection predisposes skin to toxic epidermal necrolysis via depletion of skin-directed CD4+ T cells. J Am Acad Dermatol. 2014;70(6):1096–102.

    Article  CAS  PubMed  Google Scholar 

  33. Brock MV, Hooker CM, Engels EA, Moore RD, Gillison ML, Alberg AJ, et al. Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: implications for patient care. J Acquir Immune Defic Syndr. 2006;43(1):47–55.

    Article  PubMed  Google Scholar 

  34. Puoti M, Bruno R, Soriano V, Donato F, Gaeta GB, Quinzan GP, et al. Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome. AIDS. 2004;18(17):2285–93.

    Article  PubMed  Google Scholar 

  35. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370(9581):59–67.

    Article  PubMed  Google Scholar 

  36. Grabar S, Abraham B, Mahamat A, Del Giudice P, Rosenthal E, Costagliola D. Differential impact of combination antiretroviral therapy in preventing Kaposi’s sarcoma with and without visceral involvement. J Clin Oncol. 2006;24(21):3408–14.

    Article  CAS  PubMed  Google Scholar 

  37. Polesel J, Franceschi S, Suligoi B, et al. Cancer incidence in people with AIDS in Italy. Int J Cancer. 2010;127(6):1437–45.

    Article  CAS  PubMed  Google Scholar 

  38. Franceschi S, Lise M, Clifford GM, Rickenbach M, Levi F, Maspoli M, et al. Swiss HIV Cohort Study. Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer. 2010;103(3):416–22.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  39. Hleyhel M, Belot A, Bouvier AM, et al. Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: results from the FHDH-ANRS CO4 cohort. Clin Infect Dis. 2013;57(11):1638–47.

    Article  CAS  PubMed  Google Scholar 

  40. Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol. 2010;146(3):283–7.

    Article  PubMed  Google Scholar 

  41. Webb MC, Compton F, Andrews PA, Koffman CG. Skin tumours posttransplantation: a retrospective analysis of 28 years’ experience at a single centre. Transplant Proc. 1997;29(1–2):828–30.

    Article  CAS  PubMed  Google Scholar 

  42. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med. 2003;348(17):1681–91.

    Article  PubMed  Google Scholar 

  43. Silverberg MJ, Leyden W, Warton EM, Quesenberry Jr CP, Engels EA, Asgari MM. HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer. J Natl Cancer Inst. 2013;105(5):350–60. This is a cohort study showing a higher risk of non-melanoma skin cancer in HIV patients.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work is supported by NIH grant K23DA032306.

Compliance with Ethics Guidelines

ᅟ

Conflict of Interest

We declare that we have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by the author.

Author information

Authors and Affiliations

  1. Department of Dermatology, University of Wisconsin School of Medicine & Public Health, Madison, WI, USA

    Kirstin Altman & Erin Vanness

  2. Departments of Medicine and Population Health Sciences, University of Wisconsin School of Medicine & Public Health, Madison, WI, USA

    Ryan P. Westergaard

  3. Division of Infectious Diseases, 1685 Highland Ave, MFCB 5220, Madison, WI, 53705, USA

    Ryan P. Westergaard

Authors
  1. Kirstin Altman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Erin Vanness
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ryan P. Westergaard
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ryan P. Westergaard.

Additional information

This article is part of the Topical Collection on Skin, Soft Tissue, Bone and Joint Infectious Diseases

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Altman, K., Vanness, E. & Westergaard, R.P. Cutaneous Manifestations of Human Immunodeficiency Virus: a Clinical Update. Curr Infect Dis Rep 17, 9 (2015). https://doi.org/10.1007/s11908-015-0464-y

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11908-015-0464-y

Keywords

Search

Navigation